![]() |
|
searchpremiumIHS CHEMICAL WEEK BUSINESS DAILY eventsfree featuresadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Fine Chemicals Firm AMRI Buys Excelsyn for $19 Million6:44 AM MST | February 19, 2010 | Alex Scott Pharmaceutical ingredients manufacturer and drug discovery firm AMRI (Albany, NY) says it has acquired contract fine chemicals business Excelsyn (Holywell, U.K.) for $19 million. Excelsyn had been privately owned and led by industry veteran Ian Shott... This information is only available to Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|